VICOM Ltd (SGX:WJP)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	564	464	507	681	723	766
Market Cap Growth	-8.39%	-8.39%	-25.52%	-5.88%	-5.56%	11.77%
Enterprise Value	537	442	489	647	682	719
Last Close Price	1.59	1.28	1.34	1.74	1.77	1.80
PE Ratio	19.25	15.86	18.37	26.00	29.19	31.27
PS Ratio	4.72	3.89	4.53	6.29	7.17	8.86
PB Ratio	3.96	3.26	3.83	5.44	5.64	5.65
P/TBV Ratio	4.36	3.60	4.25	6.03	6.24	6.23
P/FCF Ratio	24.47	20.16	26.87	41.30	41.62	35.27
P/OCF Ratio	16.13	13.29	16.01	26.81	24.39	20.86
EV/Sales Ratio	4.49	3.70	4.37	5.98	6.76	8.32
EV/EBITDA Ratio	12.43	10.77	12.54	16.96	18.71	24.58
EV/EBIT Ratio	15.50	12.75	14.78	19.82	22.02	30.37
EV/FCF Ratio	23.29	19.17	25.94	39.27	39.24	33.12
Debt / Equity Ratio	0.22	0.22	0.24	0.25	0.25	0.24
Debt / EBITDA Ratio	0.74	0.74	0.77	0.78	0.83	1.06
Debt / FCF Ratio	1.38	1.38	1.67	1.89	1.83	1.51
Asset Turnover	0.59	0.59	0.58	0.56	0.50	0.42
Inventory Turnover	3426.55	3426.55	3337.32	3930.84	4755.48	4240.96
Quick Ratio	2.30	2.30	2.28	2.40	2.23	2.68
Current Ratio	2.32	2.32	2.29	2.41	2.24	2.69
Return on Equity (ROE)	21.56%	21.56%	21.76%	20.97%	19.14%	18.66%
Return on Assets (ROA)	10.62%	10.62%	10.76%	10.52%	9.50%	7.17%
Return on Capital (ROIC)	12.80%	12.80%	12.93%	12.90%	11.80%	8.86%
Return on Capital Employed (ROCE)	19.60%	19.60%	20.10%	20.70%	19.30%	14.00%
Earnings Yield	5.19%	6.30%	5.44%	3.85%	3.43%	3.20%
FCF Yield	4.09%	4.96%	3.72%	2.42%	2.40%	2.83%
Dividend Yield	3.70%	4.53%	4.10%	3.81%	3.54%	3.46%
Payout Ratio	70.23%	67.20%	77.98%	88.83%	132.52%	87.90%
Total Shareholder Return	3.70%	4.53%	4.10%	3.81%	3.54%	3.46%

Updated Aug 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.